Results 71 to 80 of about 24,961 (203)
Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity
Cisplatin is a widely used chemotherapeutic drug for treating various solid tumors. Ototoxicity is a major dose-limiting side effect of cisplatin, which causes progressive and irreversible sensorineural hearing loss.
Junyeong Yi +3 more
doaj +1 more source
New Impedance Field Telemetry Heat Map for Assessing Electrode Array in MED‐EL Cochlear Implants
ABSTRACT Objective To compare MED‐EL's new impedance field telemetry (IFT) heat map interface for confirmation of surgical placement of the electrode array to conventional imaging. Methods A retrospective study was completed on 35 patients who received MED‐EL cochlear implants between 2017 and 2024 for whom both IFT and radiologic data were available ...
Christine J. Colasacco +4 more
wiley +1 more source
Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
Ototoxicity refers to damage of inner ear structures (i.e., the cochlea and vestibule) and their function (hearing and balance) following exposure to specific in-hospital medications (i.e., aminoglycoside antibiotics, platinum-based drugs), as well as a ...
C. Kros, P. Steyger
semanticscholar +1 more source
Auditory Neuropathy: Challenges and Significant Progress in Diagnosis and Treatment
Auditory neuropathy is a complex disorder that causes sensorineural hearing impairment in patients. Recently, breakthrough progress has been made in the gene therapy of auditory neuropathy. This review focuses on auditory neuropathy, covering its pathophysiology, etiology, epidemiology, clinical manifestations, diagnostic techniques, treatment ...
Wen Xie +11 more
wiley +1 more source
Ototoxicity refers to the adverse effects of substances on auditory or vestibular functions. This study examines the evidence of ototoxicity’s association with exposure to common environmental pollutants, as documented in toxicological profiles by the ...
Gregory M. Zarus +6 more
doaj +1 more source
Cisplatin (CDDP) is widely used in clinical settings for the treatment of various cancers. However, ototoxicity is a major side effect of CDDP, and there is an associated risk of irreversible hearing loss.
Y. Di +10 more
semanticscholar +1 more source
Society for Maternal‐Fetal Medicine Consult Series #76: Cancer in pregnancy
Abstract Approximately one in 1000 pregnancies is complicated by the diagnosis of cancer each year, and the incidence of cancer among reproductive‐age individuals is increasing. Management of a pregnant person with cancer can be complex and warrants a multidisciplinary approach to care.
Society for Maternal‐Fetal Medicine (SMFM) +6 more
wiley +1 more source
The audiogram of the world's first successfully captive‐born Yangtze finless porpoise was on average 40 dB higher than conspecifics. Congenital hearing disorders and noise exposure may be the primary cause of porpoise's hearing loss. ABSTRACT Aquariums globally have seen significant growth in recent decades.
Zhitao Wang +3 more
wiley +1 more source
Ototoxicity is a major dose-limiting side effect of cisplatin, a highly effective anti-cancer drug used to treat many solid tumors. Oxidative stress plays a central role in mediating cisplatin-induced ototoxicity.
Shomaila Mehmood +3 more
doaj +1 more source
Clinical aspects of hearing loss associated with cisplatin therapy – a review [PDF]
Introduction: Cisplatin is a well known platinum-based chemotherapeutic agent used for the treatment of diverse malignant tumours. A frequent side effect of cisplatin therapy is ototoxicity.
Felician Chirteş
doaj

